New City, NY, United States of America

Romulus K Brazzell

This inventor holds 3 USPTO granted patents. Top assignees: American Cyanamid Company, Other. Active years: 1993-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Romulus K Brazzell. Retrieved from https://idiyas.com/inventor/romulus-k-brazzell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 40(Granted Patents)


Location History:

  • Arlington, TX (US) (1993)
  • New City, NY (US) (1996)

Company Filing History:


Years Active: 1993-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Romulus K Brazzell: Innovator in Glaucoma Treatment

Introduction

Romulus K Brazzell is a notable inventor based in New City, NY (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma and ocular hypertension. With a total of 3 patents to his name, Brazzell's work has had a meaningful impact on medical treatments.

Latest Patents

Brazzell's latest patents focus on innovative methods for treating glaucoma. One of his inventions involves the treatment of glaucoma and ocular hypertension using a compound formula that allows for effective topical or systemic administration. Another patent details the use of beta-3-adrenergic agonists, specifically substituted 5-2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles, which are beneficial in managing elevated intraocular pressure and glaucoma.

Career Highlights

Throughout his career, Brazzell has worked with prominent organizations, including the American Cyanamid Company. His expertise in the field has led to advancements in therapeutic approaches for eye health.

Collaborations

Brazzell has collaborated with notable individuals in his field, including Bernard Dubnick and Gerald Hecht. These partnerships have contributed to the development and refinement of his innovative treatments.

Conclusion

Romulus K Brazzell's contributions to glaucoma treatment exemplify the importance of innovation in medical science. His patents and collaborations highlight his commitment to improving patient care and advancing ophthalmic therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…